Survey of Patient and Physician Knowledge and Perception Regarding Medicare Part D Plan Selection

首次发布于 2014 年 9 月 16 日

Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours

计划入组 83 人 · 首次发布于 2008 年 12 月 17 日

MaCRA Part B in Côte d'Ivoire

计划入组 231 人 · 首次发布于 2025 年 2 月 3 日

Fesoterodine(Toviaz)

C₂₆H₃₇NO₃ · Rx

D-Alanine

C₃H₇NO₂

Vitamin D(Mvc-fluoride, Vitafol-one)

Rx

Mako Gold Ltd

Anabio R&D

Vietnam

Vitamin D Society

Canada

RedHill's Talicia Gains Major Medicare Coverage Through Humana Part D Plan

Medicare Part D Expands MTM Services to Include HIV/AIDS Coverage in 2025

Medicare Part D Protected Classes See 58% Initial Rejection Rate Despite Coverage Protections